Thalidomide in the Treatment of Behçet's Syndrome

Archives of Dermatology

Volumn 118, Issue 8, 1982, Pages 536-

  Saylan, Türkan ^a   Saltik, Işik ^a  

^a NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

BEHCET DISEASE; HUMAN; LETTER; EDITORIAL; THERAPY;

BEHCET SYNDROME; HUMAN; THALIDOMIDE;

EID: 0020048343     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1982.01650200004003     Document Type: Letter

References (4)

1. Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965;6:303–306.
2. Iyer CGS, Languillon J, Ramanujam K, et al: WHO-coordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull WHO 1971;45:719–732.
3. Kawachi-Takahashi S, Takahashi M, Kogure M, et al: Elevation of serum C9 level associated with Behçet's disease. Japan Exp Med 1974;5:485–487.
4. O'Archard H: Stomatologic disorders of an internal and integumental nature, in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine, ed 2. New York, McGraw-Hill Book Co, 1979, pp 849–852.